GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,120 | -4.2% | 30,156 | +38.1% | 0.00% | 0.0% |
| Q2 2023 | $26,211 | +22495.7% | 21,843 | -76.4% | 0.00% | -75.0% |
| Q1 2023 | $116 | -22.1% | 92,436 | +34.2% | 0.00% | -33.3% |
| Q4 2022 | $149 | -99.9% | 68,888 | +336.3% | 0.01% | +100.0% |
| Q3 2022 | $189,000 | +656.0% | 15,788 | +437.7% | 0.00% | +200.0% |
| Q2 2022 | $25,000 | -64.8% | 2,936 | -64.4% | 0.00% | 0.0% |
| Q1 2022 | $71,000 | +121.9% | 8,251 | +189.4% | 0.00% | 0.0% |
| Q4 2021 | $32,000 | -66.0% | 2,851 | -62.0% | 0.00% | -50.0% |
| Q3 2021 | $94,000 | +30.6% | 7,498 | -16.1% | 0.00% | 0.0% |
| Q2 2021 | $72,000 | +242.9% | 8,932 | +293.5% | 0.00% | – |
| Q1 2021 | $21,000 | -44.7% | 2,270 | -42.6% | 0.00% | -100.0% |
| Q4 2020 | $38,000 | +35.7% | 3,958 | +77.3% | 0.00% | – |
| Q3 2020 | $28,000 | -72.5% | 2,232 | -71.5% | 0.00% | -100.0% |
| Q2 2020 | $102,000 | +277.8% | 7,819 | +357.8% | 0.00% | +100.0% |
| Q4 2019 | $27,000 | -88.7% | 1,708 | -88.0% | 0.00% | -87.5% |
| Q3 2019 | $239,000 | +7866.7% | 14,262 | +11986.4% | 0.02% | – |
| Q1 2019 | $3,000 | – | 118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
| Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
| Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
| Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
| Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
| HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
| MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
| Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
| CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
| Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |